Search Results
7 items found for "GPRC5D"
- Structural Basis for the Recognition of GPRC5D by Talquetamab, a Bispecific Antibody for Multiple Myeloma
< GPCR News < GPCRs in Oncology and Immunology Structural Basis for the Recognition of GPRC5D by Talquetamab G-protein-coupled receptor class C group 5 member D (GPRC5D), an orphan GPCR predominantly expressed microscopy, providing the basis for recognition of GPRC5D by the bispecific antibody. GPRC5D forms a symmetric homodimer with the interface between transmembrane helix (TM) 4 of one protomer The structure offers insights for optimizing antibody design against GPRC5D for relapsed or refractory
- The binding mechanism of an anti-multiple myeloma antibody to the human GPRC5D homodimer
in Oncology and Immunology The binding mechanism of an anti-multiple myeloma antibody to the human GPRC5D homodimer Published date June 19, 2024 Abstract "GPRC5D is an atypical Class C orphan G protein-coupled Here, we present the structure of GPRC5D in complex with a preclinical-stage single-chain antibody (scFv Our structural analysis reveals that the GPRC5D presents a close resemblance to the typical Class C GPCRs Furthermore, we elucidate the binding site engaging a sizable extracellular domain on GPRC5D for scFv
- Session IX / Technology capsule: Light on aGPCR signaling and function | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Several case studies of GPCR and other multi-pass transmembrane targets are presented, including GPRC5D
- Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy
< GPCR News < GPCRs in Oncology and Immunology Bispecific antibodies targeting BCMA or GPRC5D are highly
- Classified News | Dr. GPCR Ecosystem
Promote OvarianCancer Malignancy Read More December 5, 2024 Bispecific antibodies targeting BCMA or GPRC5D
- [Inhibitory effect of downregulating G protein-coupled receptor class C group 5 member A expression on lipopolysaccharide-induced inflammatory response in human gingival fibroblasts]
The expressions of GPRC5A of the two groups were detected by immunohistochemistry staining. by RT-qPCR and Western blotting analysis after GPRC5A knockdown. Meanwhile, RT-qPCR results showed that the gene expression levels of GPRC5A at different time point ( The siGPRC5A+LPS group (0.39±0.03, 1.06±0.16) also inhibited the increase of GPRC5A at both gene and Conclusions: GPRC5A expression was upregulated in periodontitis, and GPRC5A knockdown inhibited LPS-induced
- Trainee Symposium I
November 2nd / 1:45 PM - 2:45 PM Title: Virion Display to Discover a Novel Ligand of the Orphan GPCR GPRC5B